Cytotoxicity of different extracts of Mucuna pruriens seeds on hepatoma cells but not on normal hepatic cells

groupview

Abstract
Pharmacognosy Communications,2015,5,1,63-69.
Published:12-2014
Type:Research Article

Cytotoxicity of different extracts of Mucuna pruriens seeds on hepatoma cells but not on normal hepatic cells

Rajnish Kumar Yadava, Mahendra Singha, Srimanta Sarkarb, Siddhartha Maityc and Sudipta Sahaa*

aDepartment of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226025, India

bDepartment of Pharmacy, National University of Singapore, 18, Science Drive 4, Singapore 117543

cDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, India

Abstract:

Object: Cancer has become leading cause of death in India as well as world. Synthetic anticancer agents have costly and highly toxic to human body. Therefore, it is necessary to discover new therapeutic agents from natural origin for this disease. Materials and Methods: Mucuna pruriens Linn. (MP) (family Fabaceae), is widely used in folk medicine and there is no any such report on antiproliferative effects of this plant. The first objective of this study is to investigate the anticancer properties using hepatoma cells of MP seeds. The first objective of this study is to investigate the anticancer properties of MP seeds by using/on hepatoma cells. Secondly, it is necessary to explore its hepatotoxicity potential in normal cells as well. Therefore, the other objective of this study is to investigate the toxicity using normal hepatic cells. To achieve this goal, hot extraction of MP seeds were performed using petroleum ether 60-80°C (PE), ethyl acetate (EA) and Methanol (ME) as a solvent. All the three extracts were subjected to screen for anti-proliferative action using human hepatoma cell line (Huh-7 cells) at different concentrations from 0.5 to 100 μg/ml, followed by apoptotic activity using caspase-3 enzymes. On the other hand, hepatoprotective activity was performed using human primary hepatic cells (THLE-2 cells). Results: Our result collectively suggested that both EA and ME extract possessed anti-proliferative action on Huh-7 cells and less cytotoxic action on normal cells. Conclusion: Among these two extracts, it is demonstrated for the first time that ME extracts of MP seeds have cytotoxic effect on hepatoma cells but not on normal hepatic cells.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.